packageNirsevimab

nirsevimab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Nirsevimab is a monoclonal antibody used to protect against respiratory syncytial virus (RSV) infection. It is authorised in the European Union and is a relatively new, approved medicine.

Summary written by glm-5.3-flash from Wikidata Q111535760 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:nirsevimab
ATC codes:J06BD08
DrugBank:DB16258
Wikidata:Q111535760
molar mass:146300 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown